In a note to investors on Sunday, analysts at Leerink Partners called these findings “compelling,” adding that they indicate ...

Study results published in The New England Journal of Medicine show the therapy significantly improved hearing in nearly a ...

Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved ...

Genetic deficiency of otoferlin, a protein critical to synaptic transmission by the sensory hair cells of the ear, causes congenital deafness. Medicines to treat the condition are lacking; ...

Shares of Regeneron Pharmaceuticals rose nearly 0.2% in premarket trading on Monday after the drugmaker said its experimental gene therapy for hearing loss helped nearly all children in a clinical ...

Nearly all participants (11 of 12) experienced clinically meaningful hearing improvements, including three who achieved normal hearing; eight with longer follow-up showed stability or continued ...